347: More HHS upheaval, 23andMe's bankruptcy, and AI for cancer survival

Adam, Elaine, and Allison discuss the Trump administration’s plan for huge job cuts and a restructuring of the country’s top health care agencies, the approval of the first drug to treat a devastating rare disease, and the bankruptcy of 23andMe. Then, they bring on the chief executive of startup Altis Labs to discuss new data from a study they conducted with AstraZeneca on an AI tool for cancer drug development.

Episode metadata supplied by the publisher feed · Published Mar 27, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

347: More HHS upheaval, 23andMe's bankruptcy, and AI for cancer survival

0:00 31:25

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 31 minutes long.

When was this The Readout Loud episode published?

This episode was published on March 27, 2025.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!